The role of a low-dose ketamine-midazolam regimen in the management of severe painful crisis in patients with sickle cell disease

Qutaiba A. Tawfic, Ali S. Faris*, Rajini Kausalya

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

42 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The role of a low-dose ketamine-midazolam regimen in the management of severe painful crisis in patients with sickle cell disease'. Together they form a unique fingerprint.

Medicine and Dentistry